Divisions of the Pacific Heart, Lung and Blood Institute

Established in 2002, the Pacific Heart, Lung & Blood Institute (PHLBI) is a 501 (c)(3) non-profit, freestanding research institution that is committed to advancing medical research that may lead to new treatments, early detection and prevention programs for chronic disorders— including cancers of the heart, lung and blood.

The following organizations also operate under the PHLBI umbrella:

Pacific Mesothelioma Center

Pacific Mesothelioma Center The Pacific Mesothelioma Center (PMC) is known internationally for its research and clinical guidelines promoting lung-sparing therapies for malignant pleural mesothelioma (MPM).   PMC’s mission is to better serve a growing number of mesothelioma victims by supporting the first-of-its-kind and only in-house lab, in the nation.

Pacific Thymus Center

PTC logo copy There are two types of cancer of the thymus, thymomas and thymic carcinomas. Both types of thymus cancer involve epithelial tumors, which means they are located on the outside surface of the thymus gland.

Dr. Robert B. Cameron, MD FACS

Dr. Robert B. Cameron, MD FACS

Scientific Advisor for The Pacific Mesothelioma Center

Dr. Robert B. Cameron, MD FACS, a professor and senior surgeon, is one of the leading experts in North America on the treatment of pleural mesothelioma and serves as Scientific Advisor for The Pacific Mesothelioma Center.

Lien Hua-Feng, Nurse Practitioner

Lien Hua-Feng, Nurse Practitioner

Nurse Practitioner for The Pacific Mesothelioma Center

Lien Hua-Feng joined the Pacific Mesothelioma Center (PMC) at the Pacific Heart, Lung & Blood Institute (PHLBI) in February 2015. She serves as a resource to not only the PMC, but also to UCLA and the West LA Veterans Affairs Medical Center, as well as other members of the Southern California Mesothelioma Consortium.

The Greatest Escape Motorcycle Ride

UCLA Comprehensive Mesothelioma Program

Mesothelioma Symposium Highlights